Drug Search Results
Using advanced filters...
Advanced Search [+]

Vernakalant

Alternative Names: vernakalant, brinavess
Clinical Status: Inactive
Latest Update: 2025-04-10
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Potassium Channel Blocker,Sodium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Austria | Belgium | Brazil | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Estonia | European Medicines Agency | Finland | Germany | Greece | Hong Kong | Hungary | Iceland | Ireland | Israel | Italy | Latvia | Lebanon | Lithuania | Luxembourg | Netherlands | New Zealand | Norway | Poland | Portugal | Romania | Slovakia | Slovenia | South Africa | Spain | Sweden | Switzerland | United Arab Emirates | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Advanz Pharma
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 4: Atrial Fibrillation

Phase 3: Atrial Fibrillation|Atrial Flutter|Ventricular Fibrillation|Cardiac Arrhythmias|Heart Failure|Stroke

Phase 2: Atrial Fibrillation|Atrial Flutter|Stroke|Heart Failure|Cardiac Arrhythmias

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

MK-6621-049

N/A

Completed

Atrial Fibrillation

2018-04-05

2020-01-02

Patient Enrollment|Primary Endpoints|Treatments

2006-7041-83/hah

N/A

Not yet recruiting

Intestinal Diseases|Crohn Disease

None

2006-005072-40

P2

Completed

Heart Failure|Stroke|Cardiac Arrhythmias|Atrial Fibrillation

2008-07-04

2025-07-09

Treatments

1235-SR-202-AF

P2

Completed

Atrial Fibrillation

None

2022-03-12

1235-SR-1005

P2

Completed

Atrial Fibrillation|Atrial Flutter

None

2022-03-12

Primary Endpoints|Treatments

REB20-2257

P3

Not yet recruiting

Atrial Fibrillation

2025-01-01

2024-05-23

Primary Endpoints|Start Date|Treatments

MK-6621-010 AM4

P3

Completed

Atrial Fibrillation

2012-09-01

2022-03-12

Primary Endpoints

2010-018374-20

P3

Completed

Atrial Fibrillation

2012-02-20

2025-06-29

Treatments

ACT V

P3

Terminated

Atrial Fibrillation

2010-11-01

2022-03-12

Primary Endpoints|Treatments

2007-005625-29

P3

Completed

Heart Failure|Atrial Fibrillation|Stroke|Cardiac Arrhythmias|Ventricular Fibrillation

2009-11-23

2022-03-12

Treatments

AVRO

P3

Completed

Atrial Fibrillation

2009-10-01

2022-03-12

Primary Endpoints

ACT 4

P3

Completed

Atrial Fibrillation

2007-01-01

2022-03-12

Cardiome 1235-0504

P3

Completed

Atrial Flutter|Atrial Fibrillation

2005-06-01

2022-03-12

Primary Endpoints|Treatments

ACT I

P3

Completed

Atrial Fibrillation

2004-11-01

2022-03-12

Scene 2

P3

Completed

Atrial Flutter

2004-09-01

2022-03-12

Primary Endpoints|Treatments

CTR20170287

P3

Not yet recruiting

Atrial Fibrillation

None

2025-04-29

Patient Enrollment|Treatments

RAFF4 Trial

P4

Completed

Atrial Fibrillation

2024-09-15

2025-04-11

Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status

SELECTCARFAP

P4

Completed

Atrial Fibrillation

2023-06-01

2023-08-08

Primary Endpoints|Study Completion Date|Treatments|Trial Status

SELECTI-CARFAP

P4

Active, not recruiting

Atrial Fibrillation

2016-08-04

2022-03-13

Treatments

Vernakalant vs.Amiodarone Comparative Effectiveness Trial

P4

Terminated

Atrial Fibrillation

2016-02-20

2022-03-13

Treatments

MK-6621-055

P4

Withdrawn

Atrial Fibrillation

2016-02-01

2022-03-12

Primary Endpoints|Treatments

Verna-Ibu-AF

P4

Completed

Atrial Fibrillation

2015-05-12

2022-03-13

Treatments

Verna-Ibu-AF

P4

Completed

Atrial Fibrillation

2015-05-01

2019-03-19

Treatments

Vernakalant Versus Flecainide

P4

Unknown status

Atrial Fibrillation

2013-08-01

2019-03-19

Treatments

Vernakalant versus flecainide: atrial contractility

P4

Active, not recruiting

Atrial Fibrillation

2013-06-25

2022-03-13

Treatments